Vol 13, No 3 (March 29, 2024): Translational Lung Cancer Research

Original Article

Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patients
Hui Sheng, Xin He, Zhiqiang Chen, Kewei Huang, Jingjing Yang, Xiaoli Wei, Minjie Mao
Translational Lung Cancer Research  
2024;
13
(3)
:453-464
.
Outcomes of extracranial stereotactic body radiation therapy for induced oligometastatic non-small cell lung cancer on novel systemic therapy
Eyal Tsur, Philip Blumenfeld, Yakir Rottenberg, Hovav Nechushtan, Johnathan Arnon, Ori Wald, Uzi Izhar, Raphael Pfeffer, Aron Krakow, Marc Wygoda, Aron Popovtzer, Tal Falick Michaeli
Translational Lung Cancer Research  
2024;
13
(3)
:465-474
.
Revisiting the impact of clinicopathologic characteristics in PD-L1 profile in a large cohort of non-small cell lung cancer
Youngjin Kang, Seung-Eun Lee, Chul Hwan Kim, Yoo Jin Lee
Translational Lung Cancer Research  
2024;
13
(3)
:475-490
.
Additional local therapy before disease progression for EGFR-mutated advanced lung cancer: a systematic review and meta-analysis
Hayoung Seong, Soo Han Kim, Mi Hyun Kim, Jinmi Kim, Jung Seop Eom
Translational Lung Cancer Research  
2024;
13
(3)
:491-502
.
Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel
Ami Izawa, Yu Hara, Nobuyuki Horita, Suguru Muraoka, Megumi Kaneko, Ayami Kaneko, Kohei Somekawa, Momo Hirata, Yukiko Otsu, Hiromi Matsumoto, Ryo Nagasawa, Katsushi Tanaka, Sousuke Kubo, Kota Murohashi, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Nobuaki Kobayashi, Kenji Miura, Hideaki Nakajima, Takeshi Kaneko
Translational Lung Cancer Research  
2024;
13
(3)
:503-511
.
A cross-trait study of lung cancer and its related respiratory diseases based on large-scale exome sequencing population
Yunke Jiang, Hongru Li, Zaiming Li, Sha Du, Ruyang Zhang, Yang Zhao, David C. Christiani, Sipeng Shen, Feng Chen
Translational Lung Cancer Research  
2024;
13
(3)
:512-525
.
Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study
Jingyuan Xie, Ke Xu, Zijing Cai, Mo Chen, Yuxin Jiang, Jinjun Ye, Xinqing Lin, Tangfeng Lv, Ping Zhan
Translational Lung Cancer Research  
2024;
13
(3)
:526-539
.
Margin quality analysis for wedge resection of lung cancer and construction of a predictive model
Yuyan Zheng, Xinyi Wang, Chengqiang Li, Xiang Chen, Yuquan Wu, Runsen Jin, Hecheng Li
Translational Lung Cancer Research  
2024;
13
(3)
:540-551
.
Regulatory role of the miR-142-3p/CDC25C axis in modulating autophagy in non-small cell lung cancer
Jing Meng, Zongchang Song, Shuxian Cong, Qiong Sun, Qinyun Ma, Weiwei Shi, Linxuan Wang
Translational Lung Cancer Research  
2024;
13
(3)
:552-572
.
A survival nomogram model for patients with resectable non-small cell lung cancer and lymph node metastasis (N1 or N2) based on the Surveillance, Epidemiology, and End Results Database and single-center data
Cheng He, Miaoqi Ni, Jiacong Liu, Xiao Teng, Lei Ke, Yosuke Matsuura, Katsuhiro Okuda, Yuichi Sakairi, Jun Cheng, Li Yu, Wang Lv, Jian Hu
Translational Lung Cancer Research  
2024;
13
(3)
:573-586
.
The role of RASA2 in predicting radioresistance in lung cancer through regulation of p53
Jie Li, Yan Zong, Zhan Tuo, Junwei Liu, Jun Liu
Translational Lung Cancer Research  
2024;
13
(3)
:587-602
.

Surgical Technique

A simple and safe surgical technique for nonpalpable lung tumors: One-stop Solution for a nonpalpable lung tumor, Marking, Resection, and Confirmation of the surgical margin in a Hybrid operating room (OS-MRCH)
Aki Fujiwara-Kuroda, Masato Aragaki, Yasuhiro Hida, Hideki Ujiie, Kazuto Ohtaka, Haruhiko Shiiya, Kichizo Kaga, Tatsuya Kato
Translational Lung Cancer Research  
2024;
13
(3)
:603-611
.

Review Article

The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic review
Maxim Peeters, Yanina Jansen, Jean H. T. Daemen, Lori M. van Roozendaal, Paul De Leyn, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Erik R. de Loos
Translational Lung Cancer Research  
2024;
13
(3)
:612-622
.
Promising preclinical models for lung cancer research—lung cancer organoids: a narrative review
Xinru Chen, Li Ye, Hao Wang, Xinyue Liu, Lishu Zhao, Kandi Xu, Yujin Liu, Yayi He
Translational Lung Cancer Research  
2024;
13
(3)
:623-634
.
Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review
Yuxuan Wei, Lei Wang, Zheng Jin, Qingzhu Jia, Luka Brcic, Tomohiro Akaba, Qian Chu
Translational Lung Cancer Research  
2024;
13
(3)
:635-653
.

Case Report

Robot-assisted minimally invasive bronchial resection with primary anastomosis for schwannoma arising from left main bronchus: a case report
Yan Yan, Runsen Jin, Xiaoyan Chen, Yajie Zhang, Hecheng Li
Translational Lung Cancer Research  
2024;
13
(3)
:654-665
.
Hyperprogressive disease under anti-PD-1 rechallenge after initial response to anti-PD-1 treatment for non-small cell lung cancer: a case report
Shiting Xu, Takehito Shukuya, Shoko Shimamura, Takuo Hayashi, Yoshihiko Sato, Hitomi Shiozaki, Toshihiko Nishioki, Koichi Nishino, Motoyasu Kato, Aritoshi Hattori, Naoko Shimada, Kenji Suzuki, Shigehisa Kitano, Kazuhisa Takahashi
Translational Lung Cancer Research  
2024;
13
(3)
:666-672
.

Editorial Commentary

Novel immunotherapy combinations in neoadjuvant non-small cell lung cancer (NSCLC): a better chance at cure?
Alexander I. Salter, Millie Das
Translational Lung Cancer Research  
2024;
13
(3)
:673-677
.
Challenges and considerations in the immunotherapy of DLL3-positive small-cell lung cancer using IL-18 armoured chimeric antigen receptor T-cells
Roberta Mazza, John Maher, Caroline M. Hull
Translational Lung Cancer Research  
2024;
13
(3)
:678-683
.
Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors
Hidenori Kitai, Hiromichi Ebi
Translational Lung Cancer Research  
2024;
13
(3)
:684-688
.
Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target
Kazutaka Hosoya, Hiroaki Ozasa
Translational Lung Cancer Research  
2024;
13
(3)
:689-693
.
DLL3-targeted CAR T-cell therapy in pre-clinical models for small cell lung cancer: safety, efficacy, and challenges
Rebecca Y. Bellis, Prasad S. Adusumilli, Alfredo Amador-Molina
Translational Lung Cancer Research  
2024;
13
(3)
:694-698
.
ATM—the gene at the moment in non-small cell lung cancer
Kelsie L. Thu, Ju-Yoon Yoon
Translational Lung Cancer Research  
2024;
13
(3)
:699-705
.